Literature DB >> 21313662

Chemotherapy in Malignant Disease: The Present Position.

A E Buckle.   

Abstract

Year:  1961        PMID： 21313662      PMCID： PMC2482193          DOI： 10.1136/pgmj.37.428.342

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  35 in total

1.  Clinical studies of actinomycin D.

Authors:  A L WATNE; J BADILLO; A KOIKE; T KONDO; G E MOORE
Journal:  Ann N Y Acad Sci       Date:  1960-10-05       Impact factor: 5.691

2.  Effects of cancer chemotherapeutic agents on the human fetus.

Authors:  J E SOKAL; E M LESSMANN
Journal:  J Am Med Assoc       Date:  1960-04-16

3.  Role of chance observations in chemotherapy: Vinca rosea.

Authors:  R L NOBLE; C T BEER; J H CUTTS
Journal:  Ann N Y Acad Sci       Date:  1958-12-05       Impact factor: 5.691

4.  Toxic complications of treatment with 6-mercaptopurine; two cases with hepatic necrosis and intestinal ulceration.

Authors:  P A CLARK; Y E HSIA; R G HUNTSMAN
Journal:  Br Med J       Date:  1960-02-06

5.  Fluorinated pyrimidines, a new class of tumour-inhibitory compounds.

Authors:  C HEIDELBERGER; N K CHAUDHURI; P DANNEBERG; D MOOREN; L GRIESBACH; R DUSCHINSKY; R J SCHNITZER; E PLEVEN; J SCHEINER
Journal:  Nature       Date:  1957-03-30       Impact factor: 49.962

6.  Clinical studies with 5-fluorouracil.

Authors:  A R CURRERI; F J ANSFIELD; F A McIVER; H A WAISMAN; C HEIDELBERGER
Journal:  Cancer Res       Date:  1958-05       Impact factor: 12.701

7.  Clinical trials of p-(di-2-chloroethylamino)-phenylbutyric acid (CB 1348) in malignant lymphoma.

Authors:  D A GALTON; L G ISRAELS; J D NABARRO; M TILL
Journal:  Br Med J       Date:  1955-11-12

8.  Treatment of acute leukemia.

Authors:  J H BURCHENAL; M L MURPHY; C T TAN
Journal:  Pediatrics       Date:  1956-10       Impact factor: 7.124

9.  Myleran in chronic myeloid leukaemia; results of treatment.

Authors:  D A GALTON
Journal:  Lancet       Date:  1953-01-31       Impact factor: 79.321

10.  Triethylenethiophosphoramide (thio-tepa) in the treatment of neoplastic disease.

Authors:  J E ULTMANN; G A HYMAN; C CRANDALL; H NAUJOKS; A GELLHORN
Journal:  Cancer       Date:  1957 Sep-Oct       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.